Practicality meets precision: Wearable vest with integrated multi-channel PCG sensors for effective coronary artery disease pre-screening

The leading cause of mortality and morbidity worldwide is cardiovascular disease (CVD), with coronary artery disease (CAD) being the largest sub-category. Unfortunately, myocardial infarction or stroke can manifest as the first symptom of CAD, underscoring the crucial importance of early disease detection. Hence, there is a global need for a cost-effective, non-invasive, reliable, and easy-to-use system to pre-screen CAD. Previous studies have explored weak murmurs arising from CAD for classification using phonocardiogram (PCG) signals. However, these studies often involve tedious and inconvenient data collection methods, requiring precise subject preparation and environmental conditions. This study proposes using a novel data acquisition system (DAQS) designed for simplicity and convenience. The DAQS incorporates multi-channel PCG sensors into a wearable vest. The entire signal acquisition process can be completed in under two minutes, from fitting the vest to recording signals and removing it, requiring no specialist training. This exemplifies the potential for mass screening, which is impractical with current state-of-the-art protocols. Seven PCG signals are acquired, six from the chest and one from the subject’s back, marking a novel approach. Our classification approach, which utilizes linear-frequency cepstral coefficients (LFCC) as features and employs a support vector machine (SVM) to distinguish between normal and CAD-affected heartbeats, outperformed alternative low-computational methods suitable for portable applications. Utilizing feature-level fusion, multiple channels are combined, and the optimal combination yields the highest subject-level accuracy and F1-score of 80.44% and 81.00%, respectively, representing a 7% improvement over the best-performing single channel. The proposed system’s performance metrics have been demonstrated to be clinically significant, making the DAQS suitable for practical use. Moreover, the system shows promise in post-procedural monitoring for subjects undergoing percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG), effectively identifying cases of restenosis following intervention.